SK595390A3 - Pharmaceutical composition with antimycotic activity - Google Patents

Pharmaceutical composition with antimycotic activity Download PDF

Info

Publication number
SK595390A3
SK595390A3 SK5953-90A SK595390A SK595390A3 SK 595390 A3 SK595390 A3 SK 595390A3 SK 595390 A SK595390 A SK 595390A SK 595390 A3 SK595390 A3 SK 595390A3
Authority
SK
Slovakia
Prior art keywords
weight
polyethylene glycol
tetrahydrofurfuryl
pharmaceutical preparation
preparation according
Prior art date
Application number
SK5953-90A
Other languages
English (en)
Slovak (sk)
Other versions
SK280599B6 (sk
Inventor
Walter Fries
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of SK280599B6 publication Critical patent/SK280599B6/sk
Publication of SK595390A3 publication Critical patent/SK595390A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK5953-90A 1989-11-29 1990-11-29 Pharmaceutical composition with antimycotic activity SK595390A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939492A DE3939492A1 (de) 1989-11-29 1989-11-29 Pharmazeutische zubereitungen

Publications (2)

Publication Number Publication Date
SK280599B6 SK280599B6 (sk) 2000-04-10
SK595390A3 true SK595390A3 (en) 2000-04-10

Family

ID=6394433

Family Applications (1)

Application Number Title Priority Date Filing Date
SK5953-90A SK595390A3 (en) 1989-11-29 1990-11-29 Pharmaceutical composition with antimycotic activity

Country Status (29)

Country Link
US (1) US5118698A (no)
EP (1) EP0430149B1 (no)
JP (1) JPH0660097B2 (no)
KR (1) KR940000066B1 (no)
CN (1) CN1035357C (no)
AT (1) ATE102051T1 (no)
AU (1) AU626480B2 (no)
BR (1) BR9006025A (no)
CA (1) CA2030911C (no)
CY (1) CY1970A (no)
CZ (1) CZ282898B6 (no)
DE (2) DE3939492A1 (no)
DK (1) DK0430149T3 (no)
EG (1) EG19557A (no)
ES (1) ES2062271T3 (no)
FI (1) FI103713B1 (no)
HK (1) HK216896A (no)
HU (1) HU220867B1 (no)
IE (1) IE64672B1 (no)
IL (1) IL96450A (no)
MX (1) MX23518A (no)
MY (1) MY104540A (no)
NO (1) NO180475C (no)
NZ (1) NZ236255A (no)
PT (1) PT96003B (no)
RU (1) RU2038080C1 (no)
SK (1) SK595390A3 (no)
YU (1) YU227290A (no)
ZA (1) ZA909549B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
DE69129110T2 (de) * 1990-05-10 1998-12-10 Bechgaard International Research And Development A/S, Hellerup Pharmazeutische zubereitung enthaltend n-glykofurole und n-äthylenglykole
JP3485540B2 (ja) * 2000-12-28 2004-01-13 新日本製鐵株式会社 低騒音トランス
WO2002067899A1 (en) * 2001-02-28 2002-09-06 Akzo Nobel N.V. Injectable water-in-oil emulsions
ATE464880T1 (de) 2002-02-04 2010-05-15 Elan Pharma Int Ltd Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator
US20040258757A1 (en) * 2002-07-16 2004-12-23 Elan Pharma International, Ltd. Liquid dosage compositions of stable nanoparticulate active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GR79307B (no) * 1982-06-09 1984-10-22 Pfizer
AU4882685A (en) * 1984-10-19 1986-04-24 Schering Corporation 1,3-bis(1h-1,2,4-triazol-1-yl)-2-fluoro-2-(2,4- difluorophenyl) propane

Also Published As

Publication number Publication date
MY104540A (en) 1994-04-30
HUT57039A (en) 1991-11-28
EP0430149A3 (en) 1991-09-25
ATE102051T1 (de) 1994-03-15
AU6706590A (en) 1991-08-08
YU227290A (sh) 1993-10-20
EP0430149B1 (en) 1994-03-02
NO905106L (no) 1991-05-30
SK280599B6 (sk) 2000-04-10
DK0430149T3 (da) 1994-03-28
CN1035357C (zh) 1997-07-09
MX23518A (es) 1993-04-01
KR940000066B1 (ko) 1994-01-05
NO180475C (no) 1997-04-30
CZ282898B6 (cs) 1997-11-12
FI103713B (fi) 1999-08-31
ZA909549B (en) 1992-06-24
FI905814A (fi) 1991-05-30
PT96003B (pt) 1998-01-30
HU220867B1 (en) 2002-06-29
JPH03176421A (ja) 1991-07-31
JPH0660097B2 (ja) 1994-08-10
IL96450A (en) 1994-10-21
PT96003A (pt) 1991-09-13
EP0430149A2 (en) 1991-06-05
AU626480B2 (en) 1992-07-30
CZ595390A3 (en) 1997-06-11
CN1052046A (zh) 1991-06-12
NZ236255A (en) 1992-02-25
DE3939492A1 (de) 1991-06-06
CA2030911C (en) 1995-02-07
IE64672B1 (en) 1995-08-23
NO905106D0 (no) 1990-11-26
DE69007029D1 (de) 1994-04-07
FI103713B1 (fi) 1999-08-31
DE69007029T2 (de) 1994-06-09
CA2030911A1 (en) 1991-05-30
EG19557A (en) 1997-08-31
KR910009286A (ko) 1991-06-28
IE904282A1 (en) 1991-06-05
NO180475B (no) 1997-01-20
FI905814A0 (fi) 1990-11-26
US5118698A (en) 1992-06-02
BR9006025A (pt) 1991-09-24
HK216896A (en) 1996-12-27
CY1970A (en) 1997-09-05
RU2038080C1 (ru) 1995-06-27
ES2062271T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
SK281558B6 (sk) Injikovateľná kompozícia na prípravu infúzneho roztoku obsahujúca deriváty skupiny taxánov
SK12993A3 (en) Pharmaceutical composition of florfenicol
US5169847A (en) Drug solutions of increased stability and without tissue-damaging effect and process for preparing same
HU197208B (en) Process for production of medical compositions containing derivatives of oxicame
US4952575A (en) Solutions of oxaphosphorins having improved stability and process for the preparation thereof
US20190350947A1 (en) Compositions of Fosaprepitant and Methods of Preparation
EP0413538A1 (en) Long active injectable formulations containing triacetin
WO2011014541A1 (en) Stable formulations of azacitidine
SK595390A3 (en) Pharmaceutical composition with antimycotic activity
KR100884680B1 (ko) 소 동물을 위한 수의학적 주사용 조성물
US5886018A (en) Pharmaceutical composition for parenteral administration containing an indole-carboxylic acid
DE69920468T2 (de) Stabilisierte carvedilol-injektionslösung
EP2836199B1 (en) Fulvestrant formulations
HU196307B (en) Process for producing vermicides comprising levamisole-nitroxinil salt
KR20030097739A (ko) 플로르페니콜의 약제학적 조성물
US20090062295A1 (en) Pharmaceutical Products
DE2945636A1 (de) Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung
HU211580A9 (hu) Megnövelt stabilitású, szövetkárosító hatás nélküli piroxikam-oldatok Az átmeneti oltalom az 1., 2., 5. és 6. igénypontokra vonatkozik.
US20210169798A1 (en) Bendamustine Solution Formulations